Cetera Investment Advisers
APTO

Cetera Investment Advisers’s Aptose Biosciences, Inc. APTO Stock Holding History

Cetera Investment Advisers’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-640
Closed -$4.4K – 4106
2024
Q4 		$4.4K Hold
640
– – ﹤0.01% 3742
2024
Q3 		$7.89K Sell
640
-1
-0.2% -$15 ﹤0.01% 3676
2024
Q2 		$14.6K Sell
641
-70
-10% -$2.38K ﹤0.01% 3661
2024
Q1 		$35.4K Buy
+711
New +$40.7K ﹤0.01% 3598

Other funds holding APTO

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Cetera Investment Advisers's APTO Position: Q1 2025 in Review

Cetera Investment Advisers sold out of Aptose Biosciences, Inc. (APTO) in Q1 2025, closing a stake of 640 shares — an estimated $4.4K sold.

Cetera Investment Advisers first reported a position in APTO in Q1 2024 and held it in 4 quarters. The position peaked at $35.4K in Q1 2024. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.

  • Cetera Investment Advisers reported no remaining Aptose Biosciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 640 Aptose Biosciences, Inc. shares in Q1 2025, an estimated $4.4K.
  • Cetera Investment Advisers first reported a position in Aptose Biosciences, Inc. in Q1 2024 and held it in 4 quarters.
  • Cetera Investment Advisers's Aptose Biosciences, Inc. position peaked at $35.4K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.

Based on Cetera Investment Advisers's 13F filing for Q1 2025, filed 6 May 2025.